comparison of glp-1 agonists Comparing GLP-type therapies for weight loss in those without diabetes. Two glucagon-like peptide-1 receptor (GLP-1 RAs) (#semaglutide and #liraglutide) and one dual agonist (#tirzepatide) have been FDA-approved for #weightloss in adults PDB-101: Molecule of the Month:
Description
These positive results indicate that the change in myocardial cells may not be the primary driver of HFpEF
In that context, a 16% benefit is a big deal. He notes that these findings were among patients at high risk for a cardiovascular event and may not apply to lower-risk populations
Dual agonist: GLP-1 plus GIP: Tirzapeptide is a combination of GLP-1 RA and a GIP agonist that is FDA-approved for weight loss
WY and X-YY made the figures and table
Erlinger S
